British group of scientists have developed a new method for predicting the incidence of esophageal cancer.
‘The method is quicker, more affordable and very accurate in predicting cancer before it develops. It is a true breakthrough in cancer science, and it will save lives’, says the Medical Research Director at the University of Cambridge, UK.
Their research indicates that using a pill test based on the ‘sponge on a string’ approach can provide enough data from the subject to give an indication of the probability of later developing cancer for that subject.
Doctors say this may not be the least invasive test in the world, but it is a walk in the park compared to the current main method, which is endoscopy.
This new study took place in the University of Cambridge and included 468 test subjects Barrett’s esophagus. Date was collected with the new ‘sponge on a string’ test, also called cytosponge test and in combination of other test, the scientists discovered that 35% of the subjects were at a risk of developing esophageal cancer.
This sponge on a string test can help doctors predict and diagnose cancer. Small in size, when ingested the capsule goes all the way to the stomach where it dissolves, releasing a sponge.
The slightly unpleasant moment for the subject is the string which is still outside and will be used to bring back the sponge from the stomach. In just a few minutes, the sponge is brought back, collecting data as it travels along the esophagus.
With the data collected from the esophagus, doctor can predict esophageal cancer with great accuracy.
Easy to produce, less invasive than an endoscopy and much cheaper, the sponge test can help save perhaps thousands of lives every year.
This is an important step in the right direction in humanity’s fight against the global cancer epidemic.